UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 27, 2004
0-29630 | 98-0359573 |
(Commission File Number) | (I.R.S. Employer Identification No.) |
Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP England | |
(Address of principal executive offices) | (Zip code) |
Registrant’s telephone number, including area code: 44 1256 894 000
Item 5. Other Events
Shire Pharmaceuticals Group plc has issued the press releases attached as Exhibit 99.1 and Exhibit 99.2 and which are incorporated by reference herein.
Item 7. Financial Statements and Exhibits
(c) Exhibits. The following exhibits are filed herewith:
99.1 Press Release dated January 27, 2004
99.2 Press Release dated January 27, 2004
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SHIRE PHARMACEUTICALS GROUPPLC By: /s/ A C Russell |
Dated: January 27, 2004
EXHIBIT INDEX
Number Description
99.1 Press Release dated January 27, 2004
99.2 Press Release dated January 27, 2004